SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-014561
Filing Date
2017-03-14
Accepted
2017-03-14 17:30:13
Documents
56
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v459884_10q.htm 10-Q 471853
2 EXHIBIT 31.1 v459884_ex31-1.htm EX-31.1 12298
3 EXHIBIT 31.2 v459884_ex31-2.htm EX-31.2 12248
4 EXHIBIT 32.1 v459884_ex32-1.htm EX-32.1 3829
5 EXHIBIT 32.2 v459884_ex32-2.htm EX-32.2 3888
  Complete submission text file 0001144204-17-014561.txt   3958766

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rasp-20161231.xml EX-101.INS 921744
7 XBRL TAXONOMY EXTENSION SCHEMA rasp-20161231.xsd EX-101.SCH 36562
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rasp-20161231_cal.xml EX-101.CAL 21729
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rasp-20161231_def.xml EX-101.DEF 216413
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rasp-20161231_lab.xml EX-101.LAB 268658
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rasp-20161231_pre.xml EX-101.PRE 258596
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-191083 | Film No.: 17689065
SIC: 2834 Pharmaceutical Preparations